Qingdao Baheal (China) Performance
| 301015 Stock | 27.53 0.20 0.73% |
On a scale of 0 to 100, Qingdao Baheal holds a performance score of 8. The company holds a Beta of -0.18, which implies not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Qingdao Baheal are expected to decrease at a much lower rate. During the bear market, Qingdao Baheal is likely to outperform the market. Please check Qingdao Baheal's downside deviation, standard deviation, total risk alpha, as well as the relationship between the coefficient of variation and jensen alpha , to make a quick decision on whether Qingdao Baheal's historical price patterns will revert.
Risk-Adjusted Performance
8 of 100
Weak | Strong |
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Qingdao Baheal Medical are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Qingdao Baheal sustained solid returns over the last few months and may actually be approaching a breakup point. ...more
Forward Dividend Yield 0.0277 | Payout Ratio 0.5186 | Forward Dividend Rate 0.76 | Ex Dividend Date 2024-05-29 |
1 | This Week in Healthcare 500 M Raised - substack.com | 11/13/2024 |
| Begin Period Cash Flow | 793.4 M |
Qingdao |
Qingdao Baheal Relative Risk vs. Return Landscape
If you would invest 2,188 in Qingdao Baheal Medical on September 12, 2024 and sell it today you would earn a total of 565.00 from holding Qingdao Baheal Medical or generate 25.82% return on investment over 90 days. Qingdao Baheal Medical is generating 0.5103% of daily returns and assumes 4.6563% volatility on return distribution over the 90 days horizon. Simply put, 41% of stocks are less volatile than Qingdao, and 90% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Qingdao Baheal Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Qingdao Baheal's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Qingdao Baheal Medical, and traders can use it to determine the average amount a Qingdao Baheal's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1096
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | 301015 | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 4.66 actual daily | 41 59% of assets are more volatile |
Expected Return
| 0.51 actual daily | 10 90% of assets have higher returns |
Risk-Adjusted Return
| 0.11 actual daily | 8 92% of assets perform better |
Based on monthly moving average Qingdao Baheal is performing at about 8% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Qingdao Baheal by adding it to a well-diversified portfolio.
Qingdao Baheal Fundamentals Growth
Qingdao Stock prices reflect investors' perceptions of the future prospects and financial health of Qingdao Baheal, and Qingdao Baheal fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Qingdao Stock performance.
| Return On Equity | 0.31 | ||||
| Return On Asset | 0.12 | ||||
| Profit Margin | 0.09 % | ||||
| Operating Margin | 0.18 % | ||||
| Current Valuation | 15.24 B | ||||
| Shares Outstanding | 525.61 M | ||||
| Price To Book | 6.27 X | ||||
| Price To Sales | 1.81 X | ||||
| Revenue | 7.56 B | ||||
| Gross Profit | 2.08 B | ||||
| EBITDA | 999.94 M | ||||
| Net Income | 656.31 M | ||||
| Total Debt | 461.89 M | ||||
| Book Value Per Share | 4.40 X | ||||
| Cash Flow From Operations | 609.7 M | ||||
| Earnings Per Share | 1.38 X | ||||
| Total Asset | 5.3 B | ||||
| Retained Earnings | 1.45 B | ||||
About Qingdao Baheal Performance
By analyzing Qingdao Baheal's fundamental ratios, stakeholders can gain valuable insights into Qingdao Baheal's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Qingdao Baheal has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Qingdao Baheal has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Qingdao Baheal is entity of China. It is traded as Stock on SHE exchange.Things to note about Qingdao Baheal Medical performance evaluation
Checking the ongoing alerts about Qingdao Baheal for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Qingdao Baheal Medical help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Qingdao Baheal appears to be risky and price may revert if volatility continues | |
| About 78.0% of the company shares are owned by insiders or employees | |
| Latest headline from news.google.com: This Week in Healthcare 500 M Raised - substack.com |
- Analyzing Qingdao Baheal's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Qingdao Baheal's stock is overvalued or undervalued compared to its peers.
- Examining Qingdao Baheal's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Qingdao Baheal's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Qingdao Baheal's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Qingdao Baheal's stock. These opinions can provide insight into Qingdao Baheal's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Qingdao Stock analysis
When running Qingdao Baheal's price analysis, check to measure Qingdao Baheal's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Qingdao Baheal is operating at the current time. Most of Qingdao Baheal's value examination focuses on studying past and present price action to predict the probability of Qingdao Baheal's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Qingdao Baheal's price. Additionally, you may evaluate how the addition of Qingdao Baheal to your portfolios can decrease your overall portfolio volatility.
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges |